The invention discloses an external-use scald and burn
drug capable of restraining
keloid hyperplasia. The external-use scald and burn
drug is characterized by being
powder and being prepared from the following medicinal raw materials in parts by weight: 1-3 parts of mercury, 10-15 parts of
sulfur, 15-20 parts of
borax, 1-3 parts of
borneol, 1-3 parts of musk, 20-30 parts of
gypsum and 20-30 parts of calamine. A preparation method for the external-use scald and burn
drug comprises the following steps: putting the
sulfur, the mercury, the
borax, the
borneol, the calamine and
sesame oil into a marmite in parts by weight; reversely buckling a seal cover by using a china bowl, heating after completely sealing junction of a porcelain bowl and the calamine through mud; after firstly heating for half an hour with strong fire and then heating for two hours with
slow fire, naturally cooling to the
room temperature, opening the calamine to scrape off medicinal raw materials coated in the porcelain bowl, adding an appropriate amount of musk into the medicinal raw materials to obtain a mixture, mixing and
grinding the mixture into
powder and passing the
powder through a 100-mesh
sieve, so as to prepare the external-use scald and burn drug capable of restraining
keloid hyperplasia. The external-use scald and burn drug disclosed by the invention has effects of being quick in relieving pain, remarkable in
curative effect and capable of restraining
keloid hyperplasia, sterilizing, killing insects and inhibiting
bacteria, and can be used for quickly restoring an injured
cortical tissue and relieving pains of a patient.